May 13, 2011

Antipsychotic Drug Risperdal, Prosecutors Seek $1 Billion From J&J in Marketing Probe

Alzheimer's Reading Room
Federal prosecutors are seeking roughly $1 billion to resolve a long-running probe into Johnson & Johnson's marketing of the antipsychotic drug Risperdal, according to people familiar with the matter.

Officials at J&J were surprised at the size of the sum that prosecutors are seeking, according to the people familiar with the matter. Prosecutors have been citing as a benchmark a $1.4 billion settlement that Eli Lilly & Co. reached in 2009 to resolve a probe into alleged improper marketing of its antipsychotic drug Zyprexa, according to one of the people. Lilly's alleged misconduct took place over a longer period of time, this person said.

From the Wall Street Journal, go here to read more.

Subscribe to the Alzheimer's Reading Room
Enter Your Email Address

More Insight and Advice for Caregivers

Original content Bob DeMarco, the Alzheimer's Reading Room